Immatics (IMTX) Short-Term Debt repayments (2023 - 2024)
Immatics (IMTX) posted Short-Term Debt repayments of -$912620.4 for Q3 2024, up 17.08% sequentially from -$1.1 million in Q3 2023, and up 17.08% YoY from -$779503.8 in Q4 2023.
Immatics (IMTX) Short-Term Debt repayments (2023 - 2024) Analysis & Trends
Immatics has reported Short-Term Debt repayments for 2 years, with the latest figure at -$912620.4 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -912,620.41 |
| Sep 30, 2024 | -912,620.41 |
| Sep 30, 2023 | -1.10 Mn |
| Sep 30, 2023 | -1.10 Mn |